Humoral hypercalcemia of malignancy

Hypercalcemia generally develops as a late complication of malignancy; its appearance has grave prognostic significance. It remains unclear, however, whether death is associated with hypercalcemic crisis (uncontrolled or recurrent progressive hypercalcemia) or with advanced disease. Symptoms include central nervous system impairment such as delirium with prominent symptoms of personality change, cognitive dysfunction, disorientation, incoherent speech, and psychotic symptoms such as hallucinations and delusions, smooth muscle hypotonicity, and altered cardiovascular function.

Also known as: humoral hypercalcemia of malignancy, hypercalcemia of malignancy, hhm, mahc, malignancy associated hypercalcemia, malignant hypercalcemia

45 clinical trials for this condition and its sub-types.